Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 33,442 shares at $26.53 ($883K) on 2018-01-12, disclosed to the SEC on 2018-01-12.
Open-market sale of $883k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.19 | 13,599 | $356K | 40.4% |
| 2 | $26.53 | 19,843 | $526K | 59.6% |
| Total | $26.39 avg | 33,442 | $883K | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |